Harrison, M. R., Davis, P. G., Khouri, M. G., Gupta, R. T., Armstrong, A. J., McNamara, M. A., … George, D. J. (2018). EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC). In Ann Oncol (Vol. 29 Suppl 8, pp. viii623–viii624). England. https://doi.org/10.1093/annonc/mdy300.064

Harrison, M. R., P. G. Davis, M. G. Khouri, R. T. Gupta, A. J. Armstrong, M. A. McNamara, T. Zhang, et al. “EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC).” In Ann Oncol, 29 Suppl 8:viii623–24, 2018. https://doi.org/10.1093/annonc/mdy300.064.

Harrison MR, Davis PG, Khouri MG, Gupta RT, Armstrong AJ, McNamara MA, et al. EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC). In: Ann Oncol. 2018. p. viii623–4.

Harrison, M. R., et al. “EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC).” Ann Oncol, vol. 29 Suppl 8, 2018, pp. viii623–24. Pubmed, doi:10.1093/annonc/mdy300.064.

Harrison MR, Davis PG, Khouri MG, Gupta RT, Armstrong AJ, McNamara MA, Zhang T, Anand M, Onyenwoke K, Hood H, Edwardson S, Craig D, Wu Y, Healy P, Coyne B, Jones L, George DJ. EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC). Ann Oncol. 2018. p. viii623–viii624.